Advertisement
UK markets close in 1 hour 58 minutes
  • FTSE 100

    8,118.59
    +39.73 (+0.49%)
     
  • FTSE 250

    19,783.75
    +181.77 (+0.93%)
     
  • AIM

    755.19
    +2.07 (+0.27%)
     
  • GBP/EUR

    1.1674
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2504
    -0.0007 (-0.06%)
     
  • Bitcoin GBP

    51,031.67
    +528.13 (+1.05%)
     
  • CMC Crypto 200

    1,380.03
    -16.51 (-1.18%)
     
  • S&P 500

    5,074.16
    +25.74 (+0.51%)
     
  • DOW

    38,078.48
    -7.32 (-0.02%)
     
  • CRUDE OIL

    84.23
    +0.66 (+0.79%)
     
  • GOLD FUTURES

    2,357.60
    +15.10 (+0.64%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,080.46
    +163.18 (+0.91%)
     
  • CAC 40

    8,058.67
    +42.02 (+0.52%)
     

Tesaro Stock: What’s the Upside Potential?

Tesaro Stock: What’s the Upside Potential?

Tesaro (TSRO) is a commercial stage biopharmaceutical company focused on developing treatments for solid tumors. Tesaro is licensed and developing a number of oncology-related product candidates. Of the 19 analysts covering Tesaro in May, 12 analysts gave the stock a “buy” or higher rating, while seven analysts gave a “hold” rating.